Ischemic heart disease is the single largest cause of death ... JBT’s second lead drug candidate is JN-210, a viral vector that delivers an activator of miR-133 for the treatment of hypertrophic ...
A study published by researchers from the Sant Pau Research Institute (IR Sant Pau) and the Stroke Unit of Sant Pau Hospital in the Journal of Lipid Research provides new evidence on the essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback